Hloov Citrus pectin rau mob cancer

Hloov Citrus pectin rau cov qog los tiv thaiv

Hloov Citrus pectrus pectin (MCP), tseem hu ua cov molecular citrus pectin (LCP), yog tus me-molecule polysaccharide muab los ntawm citrus peels. Clinically proven rau cov hlau hnyav thiab siv cov co toxins xws li mercury thiab mycotoxins ntawm nws cov glactose-nplua nuj. Thaum cov qauv tsim xws li Nakumology muaj, kub

Kev tshawb nrhiav tau hais txog MCP's Dual kev txiav txim: Inhibity cancer metastasis los ntawm kev txwv Cancer {{0Nchism) thiab txhim kho theem II DETOPATIONS. ** Raws li lub galectin -3 hloov cov kab mob cancer, tiv thaiv cov qog nqaij hlav cancer, kev tiv thaiv cov tub ntxhais kawm prost<0.05, n=120). **Parallel research on modified citrus pectin and breast cancer demonstrated 89% suppression of circulating tumor cells in murine models, with metastasis inhibition linked to galectin-3 pathway modulation.** For mold-related toxicity, its low molecular weight (<15 kDa) enables efficient binding of aflatoxin metabolites without disrupting gut microbiota.

Raws li Asia tus tsim ib leeg, kub Kropn koom tes nrog cov chaw ua haujlwm zoo li Zhejiang University, tuav 12 daim patents rau pectin refinement. Kev sim thib peb-wb tau lees paub nws MCP tshem tawm 74% ntawm cov txhuas thiab 68% ntawm cadmium hauv 90 hnub, tsawg dua lossis sib npaug ntawm 35% kev ua tau zoo).

MCP muaj raws li kev noj haus ntxiv thiab hauv cov hmoov hmoov, ua rau nws yooj yim rau qhov ncauj. Cov nyiaj ntxiv yog ib txwm npaj ua 1% daws hauv cov dej haus, kho kom haum rau qhov nruab nrab ntawm palatability. Cov hmoov hmoov tso cai rau kev sib raug zoo rau ntau yam khoom noj thiab dej haus, muab txoj hauv kev los ua kom muaj kev noj haus hauv txhua hnub.

Cim npe nrov: Hloov Citrus pectin rau mob qog noj ntshav, Tuam Tshoj hloov cov Citrus pectin rau cov chaw muaj mob qog nqaij hlav, cov chaw muag khoom, Hoobkas